LLY

1,006.06

+1.27%↑

JNJ

209.91

+1.6%↑

ABBV

223.8

-0.55%↓

UNH

336.55

+2.68%↑

AZN

90.26

-1.28%↓

LLY

1,006.06

+1.27%↑

JNJ

209.91

+1.6%↑

ABBV

223.8

-0.55%↓

UNH

336.55

+2.68%↑

AZN

90.26

-1.28%↓

LLY

1,006.06

+1.27%↑

JNJ

209.91

+1.6%↑

ABBV

223.8

-0.55%↓

UNH

336.55

+2.68%↑

AZN

90.26

-1.28%↓

LLY

1,006.06

+1.27%↑

JNJ

209.91

+1.6%↑

ABBV

223.8

-0.55%↓

UNH

336.55

+2.68%↑

AZN

90.26

-1.28%↓

LLY

1,006.06

+1.27%↑

JNJ

209.91

+1.6%↑

ABBV

223.8

-0.55%↓

UNH

336.55

+2.68%↑

AZN

90.26

-1.28%↓

Search

Merit Medical Systems Inc

Затворен

СекторЗдравеопазване

86.53 1.34

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

85

Максимум

86.71

Ключови измерители

By Trading Economics

Приходи

-4.8M

28M

Продажби

1.7M

384M

P/E

Средно за сектора

42.621

77.671

EPS

0.92

Марж на печалбата

7.225

Служители

7,400

EBITDA

-4.4M

80M

Препоръки

By TipRanks

Препоръки

Силна покупка

12-месечна прогноза

+17.74% upside

Пазарни показатели

By TradingEconomics

Пазарна капитализация

27M

4.9B

Предишно отваряне

85.19

Предишно затваряне

86.53

Настроения в новините

By Acuity

50%

50%

195 / 374 Класиране в Healthcare

Техническа оценка

By Trading Central

Увереност

Strong Bullish Evidence

Merit Medical Systems Inc Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

10.12.2025 г., 22:02 ч. UTC

Печалби

Synopsys Sees Strong 2026 as Ansys Acquisition Boosts 4Q Revenue

10.12.2025 г., 21:46 ч. UTC

Печалби

Adobe Expects Double-Digit Recurring Revenue Growth Next Year

10.12.2025 г., 23:52 ч. UTC

Придобивния, сливания и поглъщания

Paramount Sends Letter to Warner Bros. Shareholders Saying Its Offer Is 'Superior' -- Barrons.com

10.12.2025 г., 23:43 ч. UTC

Пазарно говорене

Nikkei May Rise After Fed Rate Cut -- Market Talk

10.12.2025 г., 23:36 ч. UTC

Пазарно говорене

Gold Consolidates as Traders Digest FOMC Decision -- Market Talk

10.12.2025 г., 23:20 ч. UTC

Печалби

Oracle Reports $16.1 Billion in Revenue, Narrowly Missing Forecasts -- 2nd Update

10.12.2025 г., 23:15 ч. UTC

Печалби

Synopsys Targets Double-Digit Growth Following Ansys Acquisition -- Interview

10.12.2025 г., 22:59 ч. UTC

Пазарно говорене
Печалби
Придобивния, сливания и поглъщания

Adobe Expects Semrush Deal to Bring in New Users -- Market Talk

10.12.2025 г., 22:45 ч. UTC

Пазарно говорене

Coca-Cola's New CEO Pick Looks A Lot Like The Last One -- Market Talk

10.12.2025 г., 22:40 ч. UTC

Печалби

Synopsys Stock Rises on Earnings Beat, Higher Guidance -- Barrons.com

10.12.2025 г., 22:06 ч. UTC

Придобивния, сливания и поглъщания

Paramount Sends Letter to Warner Bros. Shareholders Saying Their Offer Is 'Superior' -- Barrons.com

10.12.2025 г., 22:06 ч. UTC

Печалби

Oracle Reports Mixed Earnings. The Stock Is Falling. -- Barrons.com

10.12.2025 г., 22:02 ч. UTC

Печалби

Synopsys Stock Rises on Earnings Beat, Higher Guidance -- Barrons.com

10.12.2025 г., 22:00 ч. UTC

Печалби

Oracle Reports $16.1 Billion in Revenue, Narrowly Missing Forecasts -- Update

10.12.2025 г., 21:53 ч. UTC

Печалби

Adobe Earnings Show 'Rapid Adoption' of AI Tools. The Stock Is Up. -- Barrons.com

10.12.2025 г., 21:50 ч. UTC

Придобивния, сливания и поглъщания

Investors Bet That a Higher Bid for Warner Is Coming -- Update

10.12.2025 г., 21:50 ч. UTC

Пазарно говорене
Печалби
Придобивния, сливания и поглъщания

Financial Services Roundup: Market Talk

10.12.2025 г., 21:50 ч. UTC

Пазарно говорене

Health Care Roundup: Market Talk

10.12.2025 г., 21:50 ч. UTC

Пазарно говорене

Auto & Transport Roundup: Market Talk

10.12.2025 г., 21:45 ч. UTC

Придобивния, сливания и поглъщания

Paramount Sends Letter to Warner Bros. Shareholders Saying Their Offer Is 'Superior' -- Barrons.com

10.12.2025 г., 21:33 ч. UTC

Печалби

Oracle Reports $16.1 Billion in Revenue, Narrowly Missing Forecasts -- WSJ

10.12.2025 г., 21:32 ч. UTC

Печалби

Oracle Reports Mixed Earnings. The Stock Is Falling. -- Barrons.com

10.12.2025 г., 21:28 ч. UTC

Придобивния, сливания и поглъщания

Sverica Capital Management Announces Sale of Coastal Cloud Holdings to Tata Consultancy Services for $700M

10.12.2025 г., 21:25 ч. UTC

Печалби

Adobe Earnings Show 'Rapid Adoption' of AI Tools. The Stock Is Up. -- Barrons.com

10.12.2025 г., 21:18 ч. UTC

Придобивния, сливания и поглъщания

Paramount Skydance: Company Has Air Tight Financing to Deliver on Warner Bros. Offer >PSKY

10.12.2025 г., 21:16 ч. UTC

Печалби

Oracle Reports Mixed Earnings. The Stock is Falling. -- Barrons.com

10.12.2025 г., 21:15 ч. UTC

Придобивния, сливания и поглъщания

Paramount Skydance: Public Offer for Warner Bros. Delivers Superior Value, Faster, More Certain Path to Completion

10.12.2025 г., 21:15 ч. UTC

Печалби

Oracle: 'Sold Ampere Because We No Longer Think It Is Strategic for Us to Continue Designing, Manufacturing and Using Our Own Chips in Our Cloud Datacenters' >ORCL

10.12.2025 г., 21:14 ч. UTC

Печалби

Oracle 2Q Non-GAAP Operating Income Was $6.7 B >ORCL

10.12.2025 г., 21:14 ч. UTC

Печалби

Oracle 2Q GAAP Operating Income Was $4.7 B >ORCL

Сравнение с други в отрасъла

Ценова промяна

Merit Medical Systems Inc Прогноза

Ценова цел

By TipRanks

17.74% нагоре

12-месечна прогноза

Среден 100.57 USD  17.74%

Висок 109 USD

Нисък 90 USD

Според 7 анализатори от Wall Street, предложили 12-месечна ценова цел за Merit Medical Systems Inc през последните три месеца.

Консенсусна оценка

By TipRanks

Силна покупка

7 ratings

6

Купи

1

Задържане

0

Продай

Техническа оценка

By Trading Central

95.585 / 96.35Подкрепа & съпротива

Краткосрочен план

Strong Bullish Evidence

Средносрочен план

Bearish Evidence

Дългосрочен план

Bearish Evidence

Настроение

By Acuity

195 / 374 Класиране в Здравеопазване

Настроения в новините

Neutral

Волатилност

Под средното

Обем новини (RCV)

Под средното

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

$

Относно Merit Medical Systems Inc

Merit Medical Systems, Inc. designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures in the United States and internationally. It operates in two segments, Cardiovascular and Endoscopy. The company provides micropuncture kits, angiographic needles, sheaths, guide wires, and safety products; peripheral intervention, including angiography, drainage, delivery systems, and embolotherapy products; spine products, such as vertebral augmentation, radiofrequency ablation, and bone biopsy systems; oncology products; and cardiac intervention products, such as access, angiography, electrophysiology and cardiac rhythm management, fluid management, hemodynamic monitoring, hemostasis, and intervention to treat various heart conditions. It also offers custom procedural solutions that include critical care products, disinfection protection systems, syringes, manifold kits, and trays and packs; coating services for medical tubes and wires; and sensor components for microelectromechanical systems. In addition, the company provides pulmonary products that consist of laser-cut tracheobronchial stents, over-the-wire and direct visualization delivery systems, and dilation balloons to endoscopically dilate structures; gastroenterology products, such as covered esophageal stents, syringe and gauges, and balloon dilators; and kits and accessories for endoscopy and bronchoscopy procedures. It sells its products to hospitals and alternate site-based physicians, technicians, and nurses through direct sales force, distributors, original equipment manufacturer partners, or custom procedure tray manufacturers. The company was incorporated in 1987 and is headquartered in South Jordan, Utah.
help-icon Live chat